579 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Unknown  Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: clomiphene citrate;   Drug: raloxifene
4 Recruiting Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: intravenous docetaxel with intraperitoneal oxaliplatin;   Drug: intravenous oxaliplatin with intraperitoneal docetaxel
5 Recruiting An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Intervention:
6 Recruiting Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
7 Recruiting Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Conditions: Pseudomyxoma Peritonei.;   Colorectal Carcinoma.;   Ovarian Carcinoma.;   Mesothelioma.
Intervention: Other: Observational study.
8 Recruiting Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study;   Other: laboratory biomarker analysis
9 Recruiting Mood and Nutrition Interventions in Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Behavioral: Cognitive Behavioral Therapy;   Behavioral: Nutrition Counseling
10 Recruiting FSH in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles
Condition: Infertility
Interventions: Drug: Urofollitrophin;   Drug: Follitrophin alpha
11 Recruiting Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
12 Recruiting Benefit of Follicular Flushing During Oocyte Retrieval for Poor Responder Patient in an Assisted Reproductive Technology Program
Conditions: Infertility, Female;   Ovarian Insufficiency
Intervention: Procedure: Direct aspiration needle Echo tip® Cook® single Lumen and Follicular flushing with double lumen needle Echo tip® Cook® Double Lumen Aspiration
13 Recruiting Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses
Conditions: Ovarian Carcinoma;   Ovarian Cancer;   Ovarian Mass;   Ovarian Cyst
Interventions: Other: Ultrasound by general gynaecologist;   Other: Ultrasound by an expert ultrasonographist;   Other: DW-MRI;   Other: Give blood sample
14 Recruiting Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Sertoli-Leydig Cell Tumor of Ovary;   Medulloepithelioma;   Embryonal Rhabdomyosarcoma of Cervix
Intervention:
15 Recruiting Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Brenner Tumor;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Stage IIA Fallopian Tube Cancer;   Stage IIA Ovarian Epithelial Cancer;   Stage IIA Primary Peritoneal Cavity Cancer;   Stage IIB Fallopian Tube Cancer;   Stage IIB Ovarian Epithelial Cancer;   Stage IIB Primary Peritoneal Cavity Cancer;   Stage IIC Fallopian Tube Cancer;   Stage IIC Ovarian Epithelial Cancer;   Stage IIC Primary Peritoneal Cavity Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer
Interventions: Behavioral: behavioral dietary intervention;   Behavioral: exercise intervention;   Other: counseling intervention;   Other: educational intervention;   Behavioral: compliance monitoring;   Other: questionnaire administration;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
16 Recruiting A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Carboplatin & paclitaxel;   Biological: Carboplatin & paclitaxel & oregovomab
17 Not yet recruiting Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility
Conditions: Breast Cancer;   Ovarian Cancer
Interventions: Behavioral: Enhanced Internet DA;   Behavioral: Internet DA;   Behavioral: Enhanced Print DA;   Behavioral: Print DA;   Behavioral: Inconclusive Results DA
18 Recruiting MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Recurrent Adult Brain Tumor;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: TORC1/2 inhibitor MLN0128;   Biological: bevacizumab;   Other: pharmacological study;   Other: laboratory biomarker analysis
19 Unknown  Letrozole Versus Clomifene Citrate for Ovulation Induction
Conditions: Infertility;   Polycystic Ovarian Syndrome
Interventions: Drug: Letrozole;   Drug: Clomifene citrate
20 Recruiting Metformin in Infertile PCOS Patients
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Metformin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years